UK Prime Minister Boris Johnson, who was hospitalised last year with a severe bout of Covid-19, has received his first dose of the AstraZeneca vaccine against the virus.
Taking to Twitter on Friday evening, Johnson said: "I've just received my first Oxford/AstraZeneca vaccine dose.
"Thank you to all of the incredible scientists, NHS (National Health Service) staff and volunteers who helped make this happen.
"Getting the jab is the best thing we can do to get back to the lives we miss so much. Let's get the jab done."
He also attached a photo of him getting the shot.
Johnson, 56, is trying to reassure the public that the AstraZeneca jab is safe after a number of countries in Europe and around the world suspended the use of it earlier this week due to blood clot fears, dpa news agency reported.
The European Union's medicines regulator issued a fresh assessment on Thursday, finding the vaccine is "safe and effective" and not associated with an increase in the overall risk of clots.
That prompted countries such as France and Germany to resume administering the jab.
French Prime Minister Jean Castex also received the AstraZeneca shot on Friday.
--IANS
ksk/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)